Septic shock epidemiology

DelveInsight launched a new report on Septic Shock Epidemiology Forecast, 2030.

Sepsis is a potentially life-threatening condition that occurs when the body’s response to an infection damages its own tissues. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Sepsis may progress to septic shock. This is a dramatic drop in blood pressure that can lead to severe organ problems and death. Early treatment with antibiotics and intravenous fluids improves chances for survival.

DelveInsight’s ‘Septic Shock Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Septic Shock epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key highlights from the Septic Shock Epidemiology Report:

  • A study conducted by Annane et al., titled “Current Epidemiology of Septic Shock,” that analyzed Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa) data base for the détermination of epidemiology of septic shock shows that in the 22 ICUs population, the overall frequency of septic shock was 8.2 per 100 ICU admissions. Its annual frequency significantly increased from 7.0 in 1993 to 9.7 per 100 ICU admissions in 2000.
  • According to a study conducted by Rhee et al., titled “Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals,” while reviewing the medical records of more than 500 patients who were admitted to six hospitals and died in the hospital or were discharged to hospice and not readmitted, sepsis was present in 52.8% hospitalizations and directly caused death in 34.9% cases. However, most underlying causes of death were related to severe chronic comorbidities and only 3.7% of sepsis-associated deaths were judged definitely or moderately preventable.

Visit for more @ Septic Shock Epidemiology Insights

Scope of the Septic Shock Epidemiology report:

  1. The Septic Shock report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
  2. The Septic Shock Epidemiology Report and Model provide an overview of the risk factors and global trends of Septic Shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  3. The report provides insight into the historical and forecasted patient pool of Septic Shock in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  4. The report helps to recognize the growth opportunities in the 7MM concerning the patient population
  5. The report assesses the disease risk and burden and highlights the unmet needs of Septic Shock
  6. The report provides the segmentation of the Septic Shock epidemiology

Table of Contents:

  1. Key Insights
  2. Executive Summary of Septic Shock
  3. Septic Shock Epidemiology Overview at a Glance
  4. Septic Shock: Disease Background and Overview
  5. Epidemiology and Patient Population
  6. Case Reports
  7. Country Wise-Epidemiology of Septic Shock 
  8. Appendix
  9. DelveInsight Capabilities
  10. Disclaimer
  11. About DelveInsight

Read more on Septic Shock Epidemiological Insights

Related Reports:

Septic Shock Market

DelveInsight’s ‘Septic Shock-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), 

Septic Shock Pipeline 

“Septic Shock Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Septic Shock market. A detailed picture of the Septic Shock pipeline landscape is provided, which includes the disease overview and Septic Shock treatment guidelines.

Latest Reports by DelveInsight

Chronic Spontaneous Urticaria Market

DelveInsight’s ‘Checkpoint Inhibitor Refractory Cancer—Market Insights, Epidemiology, and Market Forecast—2030’ report.

Diabetic Macular Edema Market

DelveInsight’s ‘Diabetic macular edema (DME)- Market Insights, Epidemiology, and Market Forecast—2030’ report.

Opium Addiction Market

DelveInsight’s “Opium Addiction – Market Insights, Epidemiology, and Market Forecast-2030” report.

Checkpoint Inhibitor Refractory Cancer

DelveInsight’s ‘Checkpoint Inhibitor Refractory Cancer—Market Insights, Epidemiology, and Market Forecast—2030’ report.

Wasting Syndrome Market

DelveInsight’s “Wasting Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” report.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Kritika Rehani

Email: [email protected]

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com

 

By sthakur

Leave a Reply

Your email address will not be published. Required fields are marked *